Overview

Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy

Status:
Completed
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Alexandria University
Treatments:
Epoetin Alfa